Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to 25.47%.

  • PROCEPT BioRobotics' EBITDA Margin rose 104900.0% to 25.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.18%, marking a year-over-year increase of 218900.0%. This contributed to the annual value of 40.71% for FY2024, which is 369800.0% up from last year.
  • According to the latest figures from Q3 2025, PROCEPT BioRobotics' EBITDA Margin is 25.47%, which was up 104900.0% from 25.19% recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' EBITDA Margin registered a high of 25.19% during Q2 2025, and its lowest value of 181.11% during Q4 2021.
  • Moreover, its 5-year median value for EBITDA Margin was 76.44% (2023), whereas its average is 91.67%.
  • In the last 5 years, PROCEPT BioRobotics' EBITDA Margin soared by 4079400bps in 2021 and then surged by 44100bps in 2023.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' EBITDA Margin stood at 181.11% in 2021, then surged by 34bps to 119.42% in 2022, then skyrocketed by 47bps to 62.9% in 2023, then soared by 56bps to 27.44% in 2024, then rose by 7bps to 25.47% in 2025.
  • Its EBITDA Margin was 25.47% in Q3 2025, compared to 25.19% in Q2 2025 and 35.61% in Q1 2025.